Targeting HER2 mutation-positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT basket trial Meeting Abstract
| Authors: | Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Cleary, J. M.; Quinn, D. I.; Brana, I.; Moreno, V.; Borad, M. J.; Loi, S.; Spanggaard, I.; Ford, J. M.; DiPrimeo, D.; Berger, M. F.; Eli, L. D.; Meric-Bernstam, F.; Solit, D. B.; Abou-Alfa, G. K. |
| Abstract Title: | Targeting HER2 mutation-positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT basket trial |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301245 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4079 |
| Notes: | Meeting Abstract: 4079 -- This meeting was also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work